Amplifi Vascular, Inc. · CIK 1990753
Amplifi Vascular, Inc.
Filings
2
Original notices
0
Amendments
2
Activity
Mar 26, 2026
through Jun 30, 2026
through Jun 30, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Mar 26, 2026 · D/A | Jun 30, 2026 · D/A | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $6,000,000 | $12,000,000 | $6,000,000 |
| Reported amount sold | $5,910,278 | $5,960,278 | $50,000 |
| Reported investor count | — | 59 | — |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0001990753-26-000003 · Later SEC source: 0001990753-26-000004
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot
- Reported offering amount
- $12,000,000
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $5,960,278
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Related person name and locality match
Matches in stored disclosures are research leads. They do not establish common ownership or confirm identity.
- NorthPoint Growth & Income Partners, LP · CIK 2161339
- NorthPoint Industrial Fund VII, LP · CIK 2043929
- NP-G REIT I LLC · CIK 2090085
- NP Industrial VII REIT 2, LP · CIK 2100279
Form D filings (2)
-
0001990753-26-000004D/A · Jun 30, 2026 · BiotechnologyOffering: $12,000,000Sold: $5,960,278
Compared with 0001990753-26-000003:
- Reported offering amount: $6,000,000 → $12,000,000
- Reported amount sold: $5,910,278 → $5,960,278
- Reported investor count: Unavailable → 59
-
0001990753-26-000003D/A · Mar 26, 2026 · BiotechnologyOffering: $6,000,000Sold: $5,910,278